Moody’s Calls Health Plan Recovery Uneven And Challenging
Bond rater and investment analyst Moody’s published a report on health plan finance and it echoes much of what I concluded from Q2 financial announcements — there are positive signs coming out of the results but pressures and challenges remain.
Overall, Moody’s says health plans surpassed investors’ expectations and most boosted their outlook, but high medical costs are still a key factor in recovery. Margin recovery and executing on financial plans to meet investor demands remains a challenge and is uneven across plans.
Interestingly, it notes that “… a significant portion of the quarter’s margin improvement reflected favorable prior-year reserve development and non-recurring items rather than solely underlying trend.”
Moody’s notes that Medicare Advantage (MA) is one of the biggest challenges, with exits from underperforming markets and retrenchment focused on higher margin populations. Products and benefits have been repriced. It opines that 2027 finalized MA rates could constrain the improvements.
Medicaid recovered somewhat but will see future impacts from the One Big Beautiful Bill Act (OBBBA) cuts.
My recent blog on the Q2 results and health plan recovery: https://www.healthcarelabyrinth.com/are-insurers-turning-the-financial-corner-yes-but-there-is-more-work-to-be-done/
My blog from Monday on the likelihood of MA going through retrenchment again in 2027: https://www.healthcarelabyrinth.com/medicare-advantage-retrenchment-is-not-over-2027-could-bring-another-tough-year/
#healthplans #margins #coverage
https://www.fiercehealthcare.com/payers/moodys-look-payers-diverging-paths-ma-aca-markets
— Marc S. Ryan
